GENIPHYS
Live / Applied — First extension granted (statement of use) (as of 16 Jan 2026)
What this means for you
Not registered yet, but its 19 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98508835
- Mark type
- Stylized text
- Filed
- 19 Apr 2024
- Published for opposition
- 21 Oct 2025
- Attorney of record
- Casey E. Wright
Goods and services
- Class 003 — Cosmetics and cleaning preparations: collagen preparations for cosmetics purposes
- Class 005 — Pharmaceuticals: collagen preparations for medical purposes; purified collagen materials from biological animal or human tissue for medical use to support tissue restoration or regeneration; purified collagen materials from biological animal or human tissue for use in medical devices in the form of implants, fillers or coatings; bone fillers consisting of biological materials; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
- Class 044 — Medical, beauty and agricultural services: providing a website featuring medical information; providing a website featuring information about collagen preparations for medical and cosmetics purposes
Owner
- GeniPhys, Inc., Indianapolis, IN, US
- GeniPhys, Inc., Indianapolis, IN, US
Prosecution history
- 17 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jan 2026 — SOU EXTENSION 1 GRANTED
- 16 Jan 2026 — SOU EXTENSION 1 FILED
- 16 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Oct 2025 — PUBLISHED FOR OPPOSITION
- 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Nov 2024 — NON-FINAL ACTION E-MAILED
- 02 Nov 2024 — NON-FINAL ACTION WRITTEN